Equillium (EQ) Operating Expenses (2018 - 2026)
Equillium (EQ) reported Operating Expenses of $5.6 million for Q1 2026, down 36.75% year-over-year from $8.9 million in Q1 2025, and up 41.6% quarter-over-quarter from $4.0 million in Q4 2025.
Equillium (EQ) Operating Expenses (2018 - 2026) Analysis & Trends
Equillium (EQ) has 9 years of Operating Expenses data on file, last reported at $5.6 million in Q1 2026.
- Operating Expenses for Q1 2026 came in at $5.6 million, down 36.75% year-over-year; the trailing twelve-month figure through Mar 2026 was $20.4 million (down 54.47% YoY), and the FY2025 annual result was $23.6 million, down 52.12% from the prior year.
- Operating Expenses grew to $5.6 million in Q1 2026 per EQ's latest filing, from $4.0 million in the prior quarter.
- Over five years, Operating Expenses peaked at $37.3 million in Q1 2022 and troughed at $4.0 million in Q4 2025.
- A 5-year average of $12.2 million and a median of $12.7 million in 2023 frame the typical range for Operating Expenses.
- The sharpest annual moves came in 2022 and 2023: Operating Expenses surged 329.32% in 2022, then plunged 65.21% in 2023.
- A 5-year view of Operating Expenses shows it stood at $13.7 million in 2022, then decreased by 9.52% to $12.4 million in 2023, then declined by 26.76% to $9.1 million in 2024, then slumped by 56.41% to $4.0 million in 2025, then surged by 41.6% to $5.6 million in 2026.
- Business Quant data shows EQ's Operating Expenses at $5.6 million in Q1 2026, $4.0 million in Q4 2025, and $4.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 4.33 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 32.68 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -138.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 15.76 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 574,669.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.85 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -67.40 Mn |
| 10 | Equillium | 293.17 Mn | 232.78 Mn | - | 5.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.61 Mn |
| Dec 31, 2025 | 3.96 Mn |
| Sep 30, 2025 | 4.58 Mn |
| Jun 30, 2025 | 6.23 Mn |
| Mar 31, 2025 | 8.87 Mn |
| Dec 31, 2024 | 9.09 Mn |
| Sep 30, 2024 | 12.84 Mn |
| Jun 30, 2024 | 13.95 Mn |
| Mar 31, 2024 | 13.48 Mn |
| Dec 31, 2023 | 12.41 Mn |
| Sep 30, 2023 | 12.49 Mn |
| Jun 30, 2023 | 12.72 Mn |
| Mar 31, 2023 | 12.99 Mn |
| Dec 31, 2022 | 13.72 Mn |
| Sep 30, 2022 | 13.24 Mn |
| Jun 30, 2022 | 13.55 Mn |
| Mar 31, 2022 | 37.33 Mn |
| Dec 31, 2021 | 10.39 Mn |
| Sep 30, 2021 | 9.86 Mn |
| Jun 30, 2021 | 8.84 Mn |